Proceedings: Bone mineral content in anticonvulsant osteomalacia

1976 ◽  
Vol 126 (6) ◽  
pp. 1302-1303 ◽  
Author(s):  
C Christiansen ◽  
P Rodbro
Keyword(s):  
Bone Mineral Content ◽  
Bone Mineral ◽  
Mineral Content

Influence of anthropometric parameters on assessment of paediatric bone mineral density and bone mineral content

2013 ◽  
Author(s):  
N Hangartner Thomas ◽  
F Short David ◽  
Gilsanz Vicente ◽  
J Kalkwarf Heidi ◽  
M Lappe Joan ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral Content ◽  
Bone Mineral ◽  
Mineral Content ◽  
Mineral Density ◽  
Anthropometric Parameters

Age at onset of walking affects bone mineral content in early childhood

2017 ◽  
Author(s):  
Saara Valkama ◽  
Heli Viljakainen ◽  
Elisa Holmlund-Suila ◽  
Jenni Rosendahl ◽  
Helena Hauta-alus ◽  
...  
Keyword(s):  
Early Childhood ◽  
Bone Mineral Content ◽  
Bone Mineral ◽  
Mineral Content ◽  
Age At Onset

Treatment with a TR[alpha]1 antagonist increases bone mineral content

2014 ◽  
Author(s):  
Julian A Waung ◽  
J H Duncan Bassett ◽  
Graham R Williams
Keyword(s):  
Bone Mineral Content ◽  
Bone Mineral ◽  
Mineral Content

Bone mineral content in the calcaneus after ankle fracture

1988 ◽  
Vol 59 (2) ◽  
pp. 173-175 ◽  
Author(s):  
Torbjorn Ahl ◽  
Hans-Erik Sjoberg ◽  
Nils Dalen
Keyword(s):  
Bone Mineral Content ◽  
Bone Mineral ◽  
Ankle Fracture ◽  
Mineral Content

Proceedings: Bone mineral content in full-term infants measured by direct photon absorptiometry

1976 ◽  
Vol 126 (6) ◽  
pp. 124-125 ◽  
Author(s):  
JJ Steichen ◽  
B Kaplan ◽  
N Edwards ◽  
RC Tsang
Keyword(s):  
Bone Mineral Content ◽  
Bone Mineral ◽  
Mineral Content ◽  
Full Term ◽  
Direct Photon ◽  
Term Infants ◽  
Photon Absorptiometry

scholarly journals Intra-Bone Marrow Administration of Mesenchymal Stem/Stromal Cells Is a Promising Approach for Treating Osteoporosis

2019 ◽  
Vol 2019 ◽  
pp. 1-10
Author(s):  
Hideki Agata ◽  
Yoshinori Sumita ◽  
Tatsuro Hidaka ◽  
Mayumi Iwatake ◽  
Hideaki Kagami ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Bone Mineral Content ◽  
Bone Mineral ◽  
Intravenous Administration ◽  
Stromal Cells ◽  
Mineral Content ◽  
Bone Diseases ◽  
Research Progress ◽  
Bone Thickness ◽  
Mineral Density

Mesenchymal stem/stromal cells (MSCs) are known to be useful for treating local bone diseases. However, it is not known if MSCs are effective for treating systemic bone diseases, as the risk for mortality following intravenous MSC administration has hindered research progress. In this study, we compared the safety and efficacy of intra-bone marrow and intravenous administration of MSCs for the treatment of ovariectomy- (OVX-) induced osteoporosis. Cells capable of forming bone were isolated from the murine compact bones and expanded in culture. Relatively pure MSCs possessing increased potential for cell proliferation, osteogenic differentiation, and inhibition of osteoclastogenesis were obtained by magnetic-activated cell sorting with the anti-Sca-1 antibody. Sca-1-sorted MSCs were administered to OVX mice, which were sacrificed 1 month later. We observed that 22% of the mice died after intravenous administration, whereas none of the mice died after intra-bone marrow administration. With respect to efficacy, intravenous administration improved bone mineral density (BMD) by increasing bone mineral content without affecting bone thickness, whereas intra-bone marrow administration improved BMD by increasing both bone mineral content and bone thickness. These results indicate that intra-bone marrow administration of pure MSCs is a safer and more effective approach for treating osteoporosis.

Sign in / Sign up

Export Citation Format

Share Document